CIM
AXNX

Contravisory Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Contravisory Investment Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-72
Closed -$3.93K – 387
2023
Q1 		$3.93K Hold
72
– – ﹤0.01% 317
2022
Q4 		$4.5K Hold
72
– – ﹤0.01% 296
2022
Q3 		$5K Buy
+72
New +$4.97K ﹤0.01% 288

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Contravisory Investment Management's AXNX Position: Q2 2023 in Review

Contravisory Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 72 shares — an estimated $3.93K sold.

Contravisory Investment Management first reported a position in AXNX in Q3 2022 and held it in 3 quarters. The position peaked at $5K in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Contravisory Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 72 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $3.93K.
  • Contravisory Investment Management first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Contravisory Investment Management's Axonics, Inc. Common Stock position peaked at $5K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Contravisory Investment Management's 13F filing for Q2 2023, filed 12 Jul 2023.